Here are some of the main highlights in ChartMaker® Medical Suite 2018.2 (file version 6.3.6). To read a full list of enhancements, view the Release Notes.
Clinical: To-Do > Direct Messaging > View Sent Messages
The User field in the Direct Messages Sent dialog has been updated with an <All Users> option that allows you to view sent messages by all users in your system. When the <All Users> option is selected, a User column will appear that will list the applicable user that the sent the message. If a message was sent by a user that was deleted from the system, <deleted> will appear in the User column for that message.
Upon upgrade, this functionality will be available as outlined above. No additional user intervention is needed.
Clinical: Prescribe Medication dialog
The Prescribe Medication, whether accessed when adding or renewing a medication, has been updated with a PDMP queried checkbox to indicate whether a Prescription Drug Monitoring Program (PDMP) system was queried prior to prescribing, or renewing, a Schedule II narcotic (Opioid) medication.
This field will automatically become checked if the PDMP Report button has been accessed but can also be manually checked or unchecked as needed. When the prescription is confirmed and saved, and the PDMP queried option was checked, the system will track that the PDMP was queried in the metadata of the audit event for the medication. Likewise, a record will be saved to the system to record that PDMP was queried for this narcotic so that numerator fulfillment can calculated for the Query of Prescription Drug Monitoring Program (PDMP) performance measure for Promoting Interoperability for MIPS 2019.
Upon upgrade, this functionality will be available as outlined above. Check or uncheck the PDMP queried option, as needed, when prescribing Schedule II (Opioid) medications.
Clinical: Reports > MIPS Dashboard > Configuration
The MIPS Dashboard Configuration dialog has been redesigned to better accommodate the size of the dialog, thereby making viewing and selecting options easier within the dialog. Do note, there may be some slight screen resizing based on the performance year selected.
The MIPS Dashboard Configuration dialog has also been updated with a new Quality Reporting option for MIPS 2019: Reporting through a combination of the EHR and STI Quality Reporting Registry. This option, which is only available for MIPS 2019 and subsequent years, allows you choose multiple collection types (i.e., submission types) for Quality Reporting. When this option is selected, the Number of measures reported field will activate allowing you to enter the number of measures you are reporting vie the STI Quality Reporting Registry. You must enter a value for this field before you can save the configuration information and exit the dialog.
Upon upgrade, this functionality will be available as outlined above. Select the applicable configuration options based on the performance period configured.
Clinical: Reports > MIPS Dashboard > Cost
The Cost category has been updated for MIPS 2019, and for the 2019 performance period will be 15% of the MIPS Total Score. Do note, as in the previous year, the Cost category will be disabled when The case minimums were not met option is selected in the Cost Case Minimums section of the MIPS Dashboard Configuration dialog.
After the Cost option has been clicked in the MIPS Dashboard, a Cost dialog will. You can then manually enter the applicable Cost Score in the corresponding field, and then click the OK button. The Category score and Weighted score for the Cost category will then be displayed in the MIPS Dashboard.
Upon upgrade, these options will be available and can be used as outlined above.
Clinical: Reports > MIPS Dashboard > Improvement Activities
The Improvement Activities dialog has been updated with new and revised improvement activities for MIPS 2019, and for the 2019 performance period will be 15% of the MIPS Total Score. These are broken up into two sub-categories (High Weighted and Medium Weighted). As in previous versions, for each entry you can click the corresponding More Info? link to view further details regarding the activity.
Upon upgrade, these options will be available as outlined above. Select the applicable activity options, as applicable.
Clinical: Reports > MIPS Dashboard > Promoting Interoperability
The Promoting Interoperability dialog has been updated with new and revised performance category measures and registry options for MIPS 2019, and for the 2019 performance period will be 25% of the MIPS Total Score.
Upon entering the Promoting Interoperability dialog for 2019, you will notice a single Performance Category Measures section, instead of the Base, Performance, and Bonus sections from previous years. Although the functionality is quite similar.
You will need to check the Performed a security risk analysis option before the Promoting Interoperability Score will be calculated. Likewise, the Submitted data to one or more public health agency or clinical data registry option will not be activated unless the Performed a security risk analysis option is selected, and performance measures, except for the PDMP and Opioid Treatment bonus measures, have been calculated and contain numerator and denominator information. Performance measures can be calculated, and reconciliation reports can be run for selected measures via the corresponding buttons.
After the Submitted data to one or more public health agency or clinical data registry option becomes active and is checked, the various registry options will become available. You can select up to a total of 10 points, or a single registry (5 points) and an exclusion, if applicable. Once a total of 10 points is selected, the other options will be grayed out. Likewise, the Exclusions checkboxes will become available for the registries after a single registry is selected, but not for the selected registry.
Only after the Performed a security risk analysis option has been selected, the performance measures have been calculated, and the registry information has been selected as applicable, will the Promoting Interoperability Score be calculated. This score will then be displayed on the Promoting Interoperability card in the MIPS Dashboard.
Upon upgrade, these options will be available as outlined above.
Clnical: Chart Notes
A new Opioid Treatment Agreement widget is available to add to chart note templates, via the Template Editor, that allows you tyou to track patients that have had a Schedule II opioid prescription for at least 30 cumulative days as identified in the patient’s medication history request and response transactions during a 6-month look-back period, and whether they have a signed opioid treatment agreement, to ensure that the Verify Opioid Treatment Agreement performance measure is calculated correctly for Promoting Interoperability for MIPS 2019.
When the Opioid Treatment Agreement widget is accessed, a Opioid Treatment Agreement dialog will appear allowing you to answer questions regarding whether the patient has had a Schedule II opioid prescription for at least 30 cumulative days as identified in the patient’s medication history request and response transactions during a 6-month look-back period, and whether they have a signed opioid treatment agreement that has been incorporated in the chart. See Figure 10. Likewise, you can access their medication history by clicking the Medication History button.
When the first question is answered in the affirmative (Yes), the system will place this patient into the denominator count for the Verify Opioid Treatment Agreement performance measure. Likewise, answering Yes to the first question will also activate the Yes and No options in the second question. If Not Asked or No is selected, then the patient will not be included in the denominator.
When the second question is answered in the affirmative (Yes), the system will place this patient in numerator count for the Verify Opioid Treatment Agreement performance measure. If Not Asked or No is selected, then the patient will not be included in the numerator.
Upon getting the upgrade, a Opioid Treatment Agreement option will be available in the Template Editor to add the Opioid Treatment Agreement widget to applicable chart note templates. Once the widget has been added to a template, simply click the Opioid Treatment Agreement button from inside a chart note to access the Opioid Treatment Agreement dialog. Then select the applicable information and options as needed, and then click the OK button once finished.